Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Frontiers in Genetics|May 22, 2023
Calculation of the pharmacogenomics benefit score for patients with medication-related problemsThomas M PolasekExpert Review of Clinical Pharmacology|February 2, 2024
Pharmacogenomics - a minor rather than major force in clinical medicineThomas M PolasekMayo Clinic Proceedings|October 11, 2005
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropeniaMatthew P Doogue, Evan J Begg, Paul BridgmanAustralian Prescriber|June 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and howSophie L Stocker, Thomas M PolasekTherapeutic Advances in Drug Safety|March 30, 2018
Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patientsHeather L Forbes, Thomas M PolasekExpert Opinion on Drug Metabolism & Toxicology|June 2, 2007
In vitro approaches to investigate mechanism-based inactivation of CYP enzymesThomas M Polasek, John O MinersFrontiers in Medicine|June 20, 2025
Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trialThomas M Polasek, Peter L FriedlandClinical Pharmacology and Therapeutics|February 8, 2024
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug ResponsesThomas M Polasek, Richard W PeckEuropean Journal of Clinical Pharmacology|January 18, 2006
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrateThomas M Polasek, John O MinersPageof 9